Demaria, Christopher John,Hartmann, Daniel Morris,Jones, Graham Barry,Kovalchick, Christopher,Pszenny, Sean Matthew,Sirkar, Rhea,Swinney, Monica Rixman
申请号：
AU2017252458
公开号：
AU2017252458A1
申请日:
2017.04.21
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
An insulin infusion set (IIS) device with one or more features designed to achieve longevity in a patients continuous subcutaneous insulin infusion (CSII) site viability. One exemplary feature is an adsorbent material configured to adsorb phenolic excipients (e.g., m-cresol or other preservatives) from the insulin formulation. The adsorbent material may be positioned along a fluid pathway specifically designed to increase and/or extend exposure between the insulin formulation and the adsorbent material. Another exemplary feature is a medicament configured to reduce the patients inflammation or slow the progression of the patients inflammatory response. Yet another exemplary feature is a diffusive catheter configured to deliver the insulin formulation in a diffuse manner.
